US Markets

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients

Credit: REUTERS/STEPHEN LAM

Gilead Inc said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.

Aug 28 (Reuters) - Gilead Inc GILD.O said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.

The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness. (https://reut.rs/31DfMIk)

(Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)

((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 8325;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GILD

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More